SCHEMBL21708677

SCHEMBL21708677

CCCC(F)OC(=O)C(CN)c1cccc(OC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 2/20 0.49
MTNR1A P48039 5/20 0.46
MTNR1B P49286 5/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
AOC3 Q16853 3/20 0.42
KDM4E B2RXH2 1/20 0.42
CASR P41180 1/20 0.41
KCNQ2 O43526 1/20 0.41
CHEK1 O14757 1/20 0.40
RPS6KA5 O75582 1/20 0.40
MAP4K4 O95819 1/20 0.40
CHEK2 O96017 1/20 0.40
PRKCG P05129 1/20 0.40
CDK1 P06493 1/20 0.40
PRKACA P17612 1/20 0.40
RPS6KB1 P23443 1/20 0.40
CDK2 P24941 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21708758 0.85 ROCK2 (0.45) ROCK2TAS1R3TAS1R1AOC3KCNQ2
SCHEMBL21708663 0.84 ROCK2 (0.44) ROCK2AOC3CASRKCNQ2MAPK1
SCHEMBL21708681 0.81 L3MBTL1 (0.46) ROCK2MTNR1AMTNR1BL3MBTL1TAS1R3
SCHEMBL30932899 0.81 L3MBTL1 (0.55) ROCK2MTNR1AMTNR1BL3MBTL1AOC3
SCHEMBL28022415 0.80 L3MBTL1 (0.57) ROCK2MTNR1AMTNR1BL3MBTL1AOC3
Hydrochloric Acid SCHEMBL5422383 0.79 ROCK2 (0.54) ROCK2MTNR1AMTNR1BL3MBTL1AOC3
SCHEMBL29381534 0.77 L3MBTL1 (0.57) MTNR1AMTNR1BL3MBTL1TAS1R3TAS1R1
SCHEMBL5181402 0.76 L3MBTL1 (0.56) ROCK2MTNR1AMTNR1BL3MBTL1AOC3
SCHEMBL21656313 0.76 L3MBTL1 (0.50) ROCK2MTNR1AMTNR1BL3MBTL1AOC3
SCHEMBL21708694 0.75 TAS1R3 (0.37) TAS1R3TAS1R1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed